指南与共识乳腺癌

理解乳腺癌复杂性以改善患者结局:2023年圣加仑早期乳腺癌个体化主要治疗国际共识会议

Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023.
指南 / 共识 · Ann Oncol · 2023-09-06

2023年3月在奥地利维也纳举行的第18届圣加仑国际乳腺癌会议评估了早期乳腺癌局部和全身治疗的重要新发现,强调多学科方法在治疗决策中的关键作用。专家组聚焦常见导管/无特殊类型和小叶乳腺癌组织学的管理争议,基于现有数据解读、当前实践及患者社会经济因素提供治疗指导。专家组强烈倡导患者在可行时参与设计良好的临床研究。

要点

  • 多学科讨论是制定具有「正确」强度与疗程的最佳治疗计划不可或缺的部分。
  • 专家组聚焦常见导管/无特殊类型和小叶乳腺癌组织学的管理争议。
  • 专家组强烈倡导患者在可行时参与设计良好的临床研究。

核心结论

  • 圣加仑共识会议旨在为临床医生提供早期乳腺癌适当治疗的指导,帮助在治疗获益与毒性之间平衡现实取舍,通过共享决策使患者和临床医生做出知情选择。

研究设计与样本

  • 第18届圣加仑国际乳腺癌会议于2023年3月在奥地利维也纳举行,评估早期乳腺癌局部和全身治疗的重要新发现,重点关注多模式治疗选择。

主要发现

  • 术前(主要或新辅助)和术后(辅助)设置中更有效创新药物的出现,凸显了多学科方法在治疗决策中的关键作用,尤其是在为个体患者选择全身治疗时。
  • 专家组聚焦常见导管/无特殊类型和小叶乳腺癌组织学的管理争议,这些组织学占绝大多数乳腺肿瘤。
  • 专家意见基于对现有数据的解读、其专业环境中的当前实践、影响患者的个人和社会经济因素,并认识到全球不同的报销和可及性限制。

临床怎么用

  • 专家组强烈倡导患者在可行时参与设计良好的临床研究。

局限性

  • 专家意见基于对现有数据的解读、其专业环境中的当前实践、影响患者的个人和社会经济因素,并认识到全球不同的报销和可及性限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The 18th St Gallen International Breast Cancer Conference held in March 2023, in Vienna, Austria, assessed significant new findings for local and systemic therapies for early breast cancer with a focus on the evaluation of multimodal treatment options. The emergence of more effective, innovative agents in both the preoperative (primary or neoadjuvant) and post-operative (adjuvant) settings has underscored the pivotal role of a multidisciplinary approach in treatment decision making, particularly when selecting systemic therapy for an individual patient. The importance of multidisciplinary discussions regarding the clinical benefits of interventions was explicitly emphasized by the consensus panel as an integral part of developing an optimal treatment plan with the 'right' degree of intensity and duration. The panelists focused on controversies surrounding the management of common ductal/no special type and lobular breast cancer histology, which account for the vast majority of breast tumors. The expert opinion of the panelists was based on interpretations of available data, as well as current practices in their professional environments, personal and socioeconomic factors affecting patients, and cognizant of varying reimbursement and accessibility constraints around the world. The panelists strongly advocated patient participation in well-designed clinical studies whenever feasible. With these considerations in mind, the St Gallen Consensus Conference aims to offer guidance to clinicians regarding appropriate treatments for early-stage breast cancer and assist in balancing the realistic trade-offs between treatment benefit and toxicity, enabling patients and clinicians to make well-informed choices through a shared decision-making process.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Curigliano G, Burstein HJ, Gnant M, et al. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023. Ann Oncol. 2023. PMID: 37683978. doi:10.1016/j.annonc.2023.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。